BlackRock’s HCW Biologics HCWB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,055
| Closed | -$11.9K | – | 5434 |
|
|
2025
Q1 | $11.9K | Sell |
1,055
-20
| -2% | -$226 | ﹤0.01% | 5116 |
|
|
2024
Q4 | $19.2K | Sell |
1,075
-34
| -3% | -$607 | ﹤0.01% | 5054 |
|
|
2024
Q3 | $23.9K | Buy |
1,109
+42
| +4% | +$906 | ﹤0.01% | 4865 |
|
|
2024
Q2 | $27.6K | Sell |
1,067
-84
| -7% | -$2.17K | ﹤0.01% | 4909 |
|
|
2024
Q1 | $80.6K | Sell |
1,151
-28
| -2% | -$1.96K | ﹤0.01% | 4722 |
|
|
2023
Q4 | $57.8K | Sell |
1,179
-14
| -1% | -$686 | ﹤0.01% | 4866 |
|
|
2023
Q3 | $90.7K | Sell |
1,193
-49
| -4% | -$3.72K | ﹤0.01% | 4806 |
|
|
2023
Q2 | $108K | Buy |
1,242
+140
| +13% | +$12.2K | ﹤0.01% | 4802 |
|
|
2023
Q1 | $61.7K | Buy |
1,102
+36
| +3% | +$2.02K | ﹤0.01% | 4993 |
|
|
2022
Q4 | $81.7K | Buy |
1,066
+24
| +2% | +$1.84K | ﹤0.01% | 5018 |
|
|
2022
Q3 | $96K | Sell |
1,042
-30
| -3% | -$2.76K | ﹤0.01% | 5097 |
|
|
2022
Q2 | $94K | Buy |
1,072
+82
| +8% | +$7.19K | ﹤0.01% | 5167 |
|
|
2022
Q1 | $108K | Buy |
990
+572
| +137% | +$62.4K | ﹤0.01% | 5182 |
|
|
2021
Q4 | $39K | Buy |
418
+11
| +3% | +$1.03K | ﹤0.01% | 5373 |
|
|
2021
Q3 | $52K | Buy |
+407
| New | +$52K | ﹤0.01% | 5212 |
|